Searchable abstracts of presentations at key conferences in endocrinology

ea0020p185 | Endocrine tumours and neoplasia | ECE2009

Estradiol influences somatostatin receptor expression and potentiates the effects of SOM230 on prostate cells

Rossi Valentina , Bellastella Giuseppe , Visconti Daniela , Abbondanza Ciro , Maione Luigi , Bellastella Antonio , Agostino Sinisi Antonio

Somatostatin (SS) receptors (SSR) expression may be modulated by estrogens in breast cancer cells. Aim of this study was to evaluate the effects of estradiol (E2) on SSR levels in prostate epithelial cells (PEC).Methods: We investigated the effects of E2 and SS-analogue SOM230 combined treatment on two PEC lines: EPN that expresses both ERalfa and beta and CPEC, showing no ERalfa and very low ERbeta expression. Cells starved in red ...

ea0032p524 | Endocrine tumours and neoplasia | ECE2013

The expression of SSTR dominant negative truncated variant sst5tMD4 influences the effects of SOM-230 on prostate cells in vitro

Rossi Valentina , Visconti Daniela , De Rosa Cristina , Abbondanza Ciro , Cioffi Iolanda , De Masi Assunta , Sinisi Antonio Agostino

Introduction: The presence of truncated variant of somatostatin receptors (SSTR) has been demonstrated in pituitary tumours. These variants seems act as dominant negative of SSTR and induce the resistance to SST analogue (SSTA) treatment. A variant of SSTR5, sst5TMD4, has been found to disrupt SST signalling in breast cancer cells. In present study, we assayed the expression of sst5TMD4 in two non-transformed epithelial prostate cell lines (EPC): EPN, derived from a normal sur...

ea0032p659 | Male reproduction | ECE2013

Effects of testosterone replacement therapy on hepcidin levels in young hypogonadal men

Palumbo Vincenzo , Esposito Dario , Visconti Daniela , Topa Adele , Rezza AnitaLa , Bellastella Giuseppe , De Bellis Annamaria , Agostino Sinisi Antonio

Erythrocytosis is a frequent adverse event associated with testosterone (T) administration in aged hypogonadal men, but the mechanisms involved remain poorly understood. T administration to aged men reduced hepcidin (Hpc) levels, a cytokine regulating iron availability, suggesting a potential role in deregulated erythropoiesis. Aim of present study was to evaluate the effects of T replacement therapy on Hpc levels in young hypogonadal men.Methods: Fifty-...

ea0022p543 | Male reproduction | ECE2010

Serum INSL3 dynamics in young men with congenital hypogonadotropic hypogonadism treated with gonadotropins

Bellastella Giuseppe , Esposito Dario , Maione Luigi , Visconti Daniela , Palumbo Vincenzo , De Bellis Annamaria , Bellastella Antonio , Sinisi Antonio Agostino

Insulin-like factor 3 (INSL3) is produced by Leydig cells. In boys, the levels of INSL3 rise at pubertal stage P2 and further increase throughout puberty in close correlation with T and LH concentrations. In men with hypogonadotropic hypogonadism (HH) INSL3 levels have been found very low and increased after short-term hCG treatment. Whether FSH plays a role in regulating INSL3 secretion is questioned. Aim of this study was to evaluate serum INSL3 levels during long-term hCG a...

ea0016oc5.3 | Reproduction | ECE2008

Prokineticin-2 and prokineticin receptor-2 gene analysis in men with Kallmann syndrome or normosmic hypogonadotropic hypogonadism

Sinisi Antonio Agostino , Asci Roberta , Bellastella Giuseppe , Esposito Dario , Maione Luigi , Visconti Daniela , Bellastella Antonio , Jolascon Achille

Prokineticins (PK1 and PK2) are peptides regulating multiple biological processes through two G-protein coupled receptors, PK-R1 and PK-R2. PK2/PKR2 signalling is critical for neurogenesis of olfactory bulb and GnRH migration. Mutant mice lacking PKR2 have abnormal development of olfactory bulb and reproductive system atrophy, suggesting that these genes may be novel candidate for Kallmann syndrome (KS) in humans. Recently, mutations in PK2 and PKR2 genes have been found in ne...

ea0016oc5.8 | Reproduction | ECE2008

The effect of estrogens plus cyproterone acetate or orchiectomy on serum insulin like factor 3 (INSL3) levels in transsexual men

Maione Luigi , Palmieri Alessandro , Bellastella Giuseppe , Visconti Daniela , Quinto Maria Chiara , De Bellis Annamaria , Mirone Vincenzo , Bellastella Antonio , Sinisi Antonio Agostino

The regulation of insulin-like factor 3 (INSL3) secretion from Leydig cells is still incompletely clarified. In this study we measured INSL3 serum levels in transsexual men under estrogen (E) and antiandrogen therapy or after orchiectomy. The effects of gonadotropins on testicular secretion in vitro was also evaluated.Methods: Blood samples were obtained from 14 transsexual men under long-term E (n=5) or E plus cyproterone acetate (E+CPA, <...

ea0016p343 | Endocrine tumours | ECE2008

Raloxifene induces growth arrest and apoptosis in prostate cell lines expressing both ERα and β

Bellastella Giuseppe , Rossi Valentina , Visconti Daniela , Palumbo Vincenzo , Chieffi Paolo , Staibano Stefania , Mascolo Giuseppe , Preziosi Domenico , Bellastella Antonio , Sinisi Antonio Agostino

Raloxifene (RAL) is a selective estrogen receptor (ER) modulator (SERM) proposed for chemoprevention of breast cancer and osteoporosis. SERMs exert agonist–antagonist effects depending on tissue or ERs expressed. RAL induces apoptosis in both androgen-dependent and independent cell lines, suggesting a selective activation of ERβ and prevalent antagonist effect on ERα in prostate cells (PC). In this study we evaluated effects of estradiol (E2) and RAL on epitheli...